% | $
Quotes you view appear here for quick access.

Neuralstem, Inc. Message Board

  • stockinsight43 stockinsight43 Sep 27, 2013 8:12 AM Flag

    Concerned about NSI-566 Phase 1 results? Are they statistically significant?

    So if I read this right, there were only 18 patients in the trial, completed at just one clinical center? And thus far only one (Ted Harada), that had any significant result? That's a 5% success rate, and with just 18 patients, is that even statistically significant?

    Sure, 1 patient that did well is better than none (heck he's walking), but the promise of NSI-566 seems a bit over stated which such a limited data set. It's even more concerning when I see the principal investigator for the study notes the same thing: "In some patients, it appears that the disease is no longer progressing, but it is too early to know if the result from that small number of patients is meaningful." Dr. Feldman is the principal investigator (PI) of the trial and an unpaid consultant to Neuralstem.

    What do other longs think?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.77-0.11(-5.85%)Jul 7 4:01 PMEDT